Management of prepregnancy, pregnancy, and postpartum obesity from the FIGO Pregnancy and Non‐Communicable Diseases Committee: A FIGO (International Federation of Gynecology and Obstetrics) guideline

Fionnuala M. McAuliffe,Sarah Louise Killeen,Chandni Maria Jacob,Mark A. Hanson,Eran Hadar,H. David McIntyre,Anil Kapur,Anne B. Kihara,Ronald C.,Hema Divakar,Moshe Hod,Ronald C. Ma
DOI: https://doi.org/10.1002/ijgo.13334
2020-09-01
Abstract:Table 1. FIGO Committee guideline for the management of prepregnancy, pregnancy, and postpartum obesity Time point A: PrepregnancyA.1All women should have their weight and height measured and their body mass index (BMI, calculated as weight in kilograms divided by height in meters squared) calculated. Consider ethnic differences.A.2All women with a BMI of ≥30 should be advised of the effect of obesity on fertility, the immediate risks of obesity during pregnancy and childbirth, and the subsequent long‐term health effect of obesity including the higher risk of noncommunicable diseases for them and their children.A.3All women with obesity should be encouraged to lose weight through diet and adopting a healthy lifestyle including moderate physical activity. If indicated and available, other weight management interventions might be considered, including bariatric surgery.A.4All women with obesity should be advised to take at least 0.4 mg (400 μg) and consider up to 5 mg folic acid supplementation daily for at least 1–3 months before conception.Time point B: PregnancyB.1All women should have their weight and height measured and their BMI calculated at the first antenatal visit. Consider ethnic differences. Advise on appropriate gestational weight gain.B.2All women should receive information on diet and lifestyle appropriate to their gestation including nutrient supplements, weight management, and regular physical activity.B.3All women with obesity should be advised of the risks of obesity and excess gestational weight gain on pregnancy, childbirth, and long‐term health including risk of noncommunicable diseases for them and their children.B.4All antenatal healthcare facilities should have well‐defined multidisciplinary pathways for the clinical management of pregnant women with obesity including the identification and treatment of pregnancy‐related complications.Time point C: PostpartumC.1All women with prepregnancy obesity should receive support on breastfeeding initiation and maintenance.C.2All women with obesity and pregnancy complications should receive appropriate postnatal follow‐up in line with local resources, care pathways, and in response to the individual health requirements of each woman and her children.C.3All women with obesity should be encouraged to lose weight post partum with emphasis on healthy diet, breastfeeding if possible, and regular moderate physical activity. They should be advised of the importance of long‐term follow‐up as they and their children are at increased risk for noncommunicable diseases.C.4Maternal obesity should be considered when making the decision regarding the most appropriate form of postnatal contraception.
obstetrics & gynecology
What problem does this paper attempt to address?